Elan Seeks Frovelan Partner, More Sales Reps For Migraine Product Launch
Elan expects to launch the migraine therapy Frovelan this year with a co-promotion partner, VP-Investor Relations John Howarth indicated March 27 at the Banc of America Securities Healthcare Conference in Las Vegas.